UMAC CFO reports 125K restricted stock grant and 8,750-share sale

Q: What insider transactions did UMAC's CFO report on this Form 4?

Unusual Machines’ Chief Financial Officer , Brian Hoff, reported two transactions dated 11/20/2025 : a grant of 125,000 shares of restricted common stock at a stated price of $0 , and a sale of 8,750 shares of common stock at $9.10 per share .

Q: How many Unusual Machines (UMAC) shares does the CFO own after these trades?

After the reported transactions, Brian Hoff beneficially owned 490,475 shares of Unusual Machines common stock , held directly.

Q: Was the UMAC CFO's stock sale part of a trading plan?

Yes. The 8,750-share sale on 11/20/2025 at $9.10 per share was executed under a Rule 10b-5 trading plan , under which the CFO had previously given an independent third party authority to sell shares.

Q: How was the UMAC CFO's restricted stock grant approved?

The grant of 125,000 shares of restricted common stock was approved by the issuer’s Compensation Committee of the Board of Directors , which is comprised of three non-employee directors, and was exempt from Section 16(b) under Rule 16b-3 .

Q: What is the role of the reporting person in Unusual Machines (UMAC)?

The reporting person, Brian Hoff , is an officer of Unusual Machines, Inc., serving as its Chief Financial Officer , as indicated in the filing.

Q: Is this Unusual Machines (UMAC) Form 4 filed for one or multiple insiders?

This Form 4 is filed by one reporting person , as indicated by the checked box for “Form filed by One Reporting Person.”

Q: What type of securities are involved in the UMAC CFO's Form 4?

The Form 4 reports transactions in Unusual Machines common stock , including restricted common stock and shares of common stock sold in the open market.

Filing Impact

(Neutral)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Unusual Machines, Inc. (UMAC) reported insider activity by its Chief Financial Officer, Brian Hoff. On 11/20/2025, he received a grant of 125,000 shares of restricted common stock at a stated price of $0, bringing his beneficial holdings higher before a same-day sale. Also on 11/20/2025, he sold 8,750 shares of common stock at $9.10 per share, and after these transactions he beneficially owned 490,475 shares, held directly. The restricted stock grant was approved by the issuer’s Compensation Committee under Rule 16b-3, and the sale was executed under a pre-established Rule 10b-5 trading plan administered by an independent third party.

Insider Trade Summary

Net Seller: 8,750 shares ($79,625)

Net Sell 2 txns

Insider Hoff Brian Joseph

Role Chief Financial Officer

Sold 8,750 shs ($80K)

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	125,000	$0.00	--
Sale	Common Stock	8,750	$9.10	$80K

Holdings After Transaction: Common Stock — 499,225 shares (Direct)

Footnotes (1)

The grant of shares of restricted common stock was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved by the Compensation Committee of the Board of Directors of the Issuer, which is comprised of three non-employee directors in accordance with Rule 16b-3(d). The shares were sold pursuant to a Rule 10b-5 plan under which the Reporting Person previously gave an independent third party the power to sell shares.

Form 4 Insider Transactions: What Each Field Means →

11/21/2025 - 04:10 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hoff Brian Joseph

(Last)

(First)

(Middle)

4677 L B MCLEOD ROAD, SUITE J

(Street)

ORLANDO

32811

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Unusual Machines, Inc. [ UMAC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
11/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock⁽¹⁾	11/20/2025		A		125,000	A	$0	499,225	D
Common Stock⁽²⁾	11/20/2025		S		8,750	D	$9.1	490,475	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The grant of shares of restricted common stock was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved by the Compensation Committee of the Board of Directors of the Issuer, which is comprised of three non-employee directors in accordance with Rule 16b-3(d).

2. The shares were sold pursuant to a Rule 10b-5 plan under which the Reporting Person previously gave an independent third party the power to sell shares.

	/s/ Brian Hoff	11/21/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did UMAC's CFO report on this Form 4?

Unusual Machines’ Chief Financial Officer, Brian Hoff, reported two transactions dated 11/20/2025: a grant of 125,000 shares of restricted common stock at a stated price of $0, and a sale of 8,750 shares of common stock at $9.10 per share.

How many Unusual Machines (UMAC) shares does the CFO own after these trades?

After the reported transactions, Brian Hoff beneficially owned 490,475 shares of Unusual Machines common stock, held directly.

Was the UMAC CFO's stock sale part of a trading plan?

Yes. The 8,750-share sale on 11/20/2025 at $9.10 per share was executed under a Rule 10b-5 trading plan, under which the CFO had previously given an independent third party authority to sell shares.

How was the UMAC CFO's restricted stock grant approved?

The grant of 125,000 shares of restricted common stock was approved by the issuer’s Compensation Committee of the Board of Directors, which is comprised of three non-employee directors, and was exempt from Section 16(b) under Rule 16b-3.

What is the role of the reporting person in Unusual Machines (UMAC)?

The reporting person, Brian Hoff, is an officer of Unusual Machines, Inc., serving as its Chief Financial Officer, as indicated in the filing.

Is this Unusual Machines (UMAC) Form 4 filed for one or multiple insiders?

This Form 4 is filed by one reporting person, as indicated by the checked box for “Form filed by One Reporting Person.”

What type of securities are involved in the UMAC CFO's Form 4?

The Form 4 reports transactions in Unusual Machines common stock, including restricted common stock and shares of common stock sold in the open market.